New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Jaguar Animal Health, Inc. (JAGX) vs Lantern Pharma Inc. (LTRN)

Jaguar Animal Health, Inc. and Lantern Pharma Inc. are both Biotechnology companies. Jaguar Animal Health, Inc. and Lantern Pharma Inc. are of similar size ($4.9M and $4.7M). Lantern Pharma Inc. has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.0×. Lantern Pharma Inc. has the higher net margin (0.00% vs −181.8%) and the higher return on invested capital (0.00% vs −117.8%). Across the 14 metrics below, Jaguar Animal Health, Inc. leads on 7 and Lantern Pharma Inc. on 7.

Valuation

Metric JAGX LTRN Biotechnology median
P/E 0.00 n/m 8.26
P/S 0.01 n/m 9.20
P/B 0.01 2.68 2.09
Price to free cash flow n/m n/m 24.49
EV/EBITDA 0.09 0.22 0.67
EV/Sales (0.07) n/m 9.05
Earnings yield 1,191,810.72% (420.86%) (34.24%)
Free cash flow yield (3,475.67%) (339.75%) (24.77%)

Profitability

Metric JAGX LTRN Biotechnology median
Gross margin 81.47% 0.00% 70.18%
Operating margin (91.15%) 0.00% 0.00%
Net margin (181.84%) 0.00% 0.00%
Free cash flow margin (25.58%) 0.00% 0.00%
Return on equity (480.38%) (250.59%) (51.58%)
Return on assets (120.10%) (124.41%) (45.91%)
Return on invested capital (117.79%) 0.00% 0.00%

Growth

Metric JAGX LTRN Biotechnology median
Revenue growth (TTM) 129.74% — 7.20%
EPS growth (last fiscal year) 82.42% 18.65% 29.04%
Revenue growth, 5-year CAGR 4.17% — 9.48%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JAGX LTRN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.28 1.49 4.83
Net debt to EBITDA (0.17) 0.56 1.01

Dividend

Metric JAGX LTRN Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric JAGX LTRN Biotechnology median
Market cap 4.71m 4.92m 155.23m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack